Loading…
XOMA Royalty is a biotech royalty aggregator that acquires the economic rights to future milestone and royalty payments associated with partnered pre-commercial clinical candidates. The company provides non-dilutive, non-recourse funding to biotech firms in exchange for these rights, managing a portfolio of over 120 assets.
AI named XOMA Royalty in December 2025.